Amarin reported $963.03M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amarin AMRN:US $ 963.03M 32.95M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
AstraZeneca AZN:LN 26.69B 583M
Epizyme EPZM:US $ 247.6M 24.89M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
GlaxoSmithKline GSK:LN 18.25B 688M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M